Scientists at the University of Geneva have created the first detailed catalogue of gut bacteria at the subspecies level, ...
Scientists at UNIGE have created an artificial intelligence method that can diagnose colorectal cancer by analyzing the gut ...
A new blood-based HPV whole genome sequencing assay can detect circulating tumor HPV DNA more than 7 years before the ...
Development and Validation of an Ipsilateral Breast Tumor Recurrence Risk Estimation Tool Incorporating Real-World Data and Evidence From Meta-Analyses: A Retrospective Multicenter Cohort Study Data ...
Researchers have developed a non-invasive stool test that detects colorectal cancer with nearly 90% accuracy by analyzing gut bacteria at the subspecies level. This innovative test offers a more ...
Researchers hope the advanced warning could enable earlier, less invasive treatments with fewer side effects and better outcomes.
The Destinex assay revolutionizes gastric cancer detection with high accuracy, offering a noninvasive, cost-effective liquid biopsy for early diagnosis.
NucleoBio, Corp., a leading biotechnology innovator in precision oncology diagnostics, and PreCheck Health Services, a high-complexity CLIA-certified and CAP-accredited clinical laboratory, today ...
The market is poised for growth due to rising demand for early detection technologies, integration with AI & imaging ...
Morning Overview on MSN
AI detects rare diseases from voice
Artificial Intelligence (AI) is significantly impacting the healthcare sector, particularly in diagnosing rare diseases. One ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback